A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.

• मुख्य लेखकों: Ermias Diro (लेखक), Severine Blesson (लेखक), Tansy Edwards (लेखक), Koert Ritmeijer (लेखक), Helina Fikre (लेखक), Henok Admassu (लेखक), Aderajew Kibret (लेखक), Sally J Ellis (लेखक), Clelia Bardonneau (लेखक), Eduard E Zijlstra (लेखक), Peninah Soipei (लेखक), Brian Mutinda (लेखक), Raymond Omollo (लेखक), Robert Kimutai (लेखक), Gabriel Omwalo (लेखक), Monique Wasunna (लेखक), Fentahun Tadesse (लेखक), Fabiana Alves (लेखक), Nathalie Strub-Wourgaft (लेखक), Asrat Hailu (लेखक), Neal Alexander (लेखक), Jorge Alvar (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Public Library of Science (PLoS), 2019-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

<h4>Background</h4>Visceral leishmaniasis (VL) in human immunodeficiency virus (HIV) co-infected patients requires special case management. AmBisome monotherapy at 40 mg/kg is recommended by the World Health Organization. The objective of the study was to assess if a combination of a low...